Latest AI and machine learning research in diabetes for healthcare professionals.
BACKGROUND: Diabetic kidney disease (DKD) is the primary global cause of end-stage renal disease. Ho...
AIMS: One in 10 patients present to the emergency department (ED) with symptoms of acute coronary sy...
Ophthalmology diseases are among the leading causes of vision loss worldwide. Glaucoma, diabetic ret...
INTRODUCTION AND AIM: Insulin resistance and obesity are significant metabolic risk factors for peri...
OBJECTIVE: We aimed to use machine learning (ML) models to investigate the impact of clinical, socia...
Microneedle patches have emerged as promising platforms for diabetic wound repair, yet their clinica...
OBJECTIVE: Non-communicable diseases (NCDs) are a growing health burden in low- and middle-income co...
BACKGROUND: Metformin, lisinopril, and atorvastatin rank among the most commonly prescribed medicati...
BACKGROUND: Type 2 diabetes mellitus (T2DM) affects approximately 590 million people worldwide, and ...
Type 2 diabetes mellitus (T2DM) is a prevalent chronic condition, particularly in the elderly, and i...
OBJECTIVES: To develop a generalizable framework for identifying algorithmic discrimination risks ar...
BACKGROUND: While HbA1c is the standard for monitoring long-term glycaemic control, it fails to capt...
Rapid and reliable prescreening and early risk stratification of postoperative meningitis (PNM) rema...
Introduction: diabetes mellitus increases the risk of cognitive impairment, but the role of dietary ...
Artificial intelligence (AI) is becoming an integral tool in clinical care. The recent position stat...
BACKGROUND: IgA nephropathy (IgAN) has diverse clinical presentations and responses to treatment. Fo...
Hypercholesterolemia (HCh) represents a prevalent comorbidity in patients with diabetic foot ulcers ...
This study developed a machine learning framework for stratifying abnormal glucose tolerance risk am...
BACKGROUND: Type 1 diabetes mellitus (T1DM) in children requires sustained self-management to achiev...
BACKGROUND: Progressive pancreatic β-cell dysfunction constitutes a hallmark of type 2 diabetes (T2D...
BACKGROUND: Orforglipron (ORF), the first orally bioavailable non-peptide glucagon-like peptide-1 re...